Date published: 2026-7-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

MHC class I Inhibitors

MHC class I inhibitors belong to a chemical class designed to modulate the activity of major histocompatibility complex class I (MHC I) molecules. MHC class I molecules are cell surface proteins present on nearly all nucleated cells in vertebrates. They play a pivotal role in the immune system by presenting peptide fragments found in intracellular proteins to CD8+ T cells, thereby facilitating immune recognition and response against infected or abnormal cells. Inhibitors within the MHC class I class are developed to interfere with the binding and presentation of antigenic peptides by MHC I molecules. By modulating the interaction between MHC I and antigenic peptides, these inhibitors can impact the activation of CD8+ T cells and alter the immune response to specific antigens. The study of MHC class I inhibitors provides valuable insights into the mechanisms of antigen presentation and immune surveillance, shedding light on the molecular processes that govern immune recognition and activation. This class of inhibitors contributes to a deeper understanding of the immune system's ability to distinguish between self and non-self, and how this recognition is vital for maintaining immune homeostasis and defending against various threats.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Inhibits the proteasome, disrupting antigen processing and MHC class I presentation by degrading proteins.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Similar to Bortezomib, MG132 also inhibits proteasome activity to affect antigen presentation.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Another proteasome inhibitor that impairs MHC class I presentation by disrupting protein degradation.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Binds to and inhibits the proteasome, leading to a reduction in MHC class I antigen presentation.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

A proteasome inhibitor that interferes with protein degradation, affecting MHC class I pathway.

NLG919

1402836-58-1sc-478118
10 mg
$352.00
(0)

Inhibits the enzyme IDO1, reducing tryptophan catabolism and promoting better MHC class I responses.

Auranofin

34031-32-8sc-202476
sc-202476A
sc-202476B
25 mg
100 mg
2 g
$153.00
$214.00
$4000.00
39
(2)

Modulates thioredoxin reductase, influencing MHC class I presentation by altering redox status.

2-Methoxyestradiol

362-07-2sc-201371
sc-201371A
10 mg
50 mg
$71.00
$288.00
6
(1)

Disrupts microtubule dynamics, affecting antigen trafficking and MHC class I presentation.

6-Formylindolo[3,2-b]carbazole

172922-91-7sc-300019A
sc-300019
100 µg
5 mg
$105.00
$2185.00
5
(0)

Binds to and activates the aryl hydrocarbon receptor (AhR), influencing MHC class I pathways.

Leflunomide

75706-12-6sc-202209
sc-202209A
10 mg
50 mg
$20.00
$83.00
5
(1)

Interferes with de novo pyrimidine synthesis, indirectly affecting MHC class I presentation.